Testing best bolus timing with MiniMed 780G pump
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial is testing the best timing for bolus insulin doses (before vs. during a meal) in people using the MiniMed 780G pump. It may help you learn how to better manage your blood sugar after meals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 1 diabetes for at least 3 years
- You are between 18 and 70 years old
- You have been using the MiniMed 780G insulin pump for at least 3 months
- You use Novorapid insulin in your pump for at least 2 weeks
- Your blood sugar stays in target range (70-180 mg/dL) more than 70% of the time
- You count carbohydrates and use a bolus calculator for your insulin doses
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares taking your rapid insulin at mealtime versus after a meal when using the Medtronic 780G pump. It aims to see which timing helps better manage blood sugar.
This trial tests whether a special exercise setting (SmartGuard) on the MiniMed 780G insulin pump helps manage blood sugar during physical activity better than the standard setting (Temp Target). If you have type 1 diabetes and regularly exercise, this study could help find the best way to use your pump during workouts.
This study tests two methods for deciding how much insulin to take with meals: counting exact carbohydrates or using a simpler meal-size guide. It aims to see which approach works best for people with type 1 diabetes who already use multiple daily injections and have moderate to high blood sugar levels (HbA1c 7.5% to under 11%).
This study tests a new automated insulin pump system (NMX8) for adults with type 1 diabetes whose blood sugar is not well controlled (HbA1c above 7.5%). You must already be using a similar pump system. The goal is to see if this new device can help you get better control.
This trial tests if a quick-acting glucagon nasal spray can prevent low blood sugar after meals in people with type 1 diabetes who use an automated insulin pump. If you count carbs and use NovoRapid or Fiasp insulin, this could help you avoid post-meal lows.
This trial tests whether following a Mediterranean diet can improve blood sugar control and insulin use in people with type 1 diabetes who are starting a new insulin pump (MiniMed 780G). It compares how diet affects glucose levels and insulin needs.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.